Q&A: How studying two different viruses can lead to new strategies for more potent antiviral treatments

Rockefeller virologist Theodora Hatziioannou explores parallels between HIV-1 and SARS-CoV-2 to develop better antiviral treatments. This cross-virus research may lead to more effective therapies for both diseases.